{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T02:48:20Z","timestamp":1774320500682,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Racial and Ethnic Health Disparities"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s40615-024-01973-7","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T19:01:46Z","timestamp":1710961306000},"page":"1416-1422","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The effect of race\/ethnicity on cancer-specific mortality after trimodal therapy"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0494-7839","authenticated-orcid":false,"given":"Mario","family":"de Angelis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Baudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolin","family":"Siech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Letizia Maria Ippolita","family":"Jannello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Di Bello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan A.","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Longo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ottavio","family":"de Cobelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix K. H.","family":"Chun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred","family":"Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Carmignani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Gandaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Moschini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Montorsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre I.","family":"Karakiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,20]]},"reference":[{"key":"1973_CR1","doi-asserted-by":"crossref","unstructured":"De Angelis M, Basile G, Scornajenghi CM, Asero V, Del Giudice F, Moschini M. Bladder-sparing strategies in patients with clinically localized muscle-invasive bladder cancer. Vol. 33, Current Opinion in Urology. Lippincott Williams and Wilkins; 2023. p. 354\u20139.","DOI":"10.1097\/MOU.0000000000001113"},{"issue":"1","key":"1973_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","volume":"79","author":"JA Witjes","year":"2021","unstructured":"Witjes JA, Bruins HM, Cathomas R. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: summary of the 2020 guidelines. Eur Urol. 2021;79(1):82\u2013104.","journal-title":"Eur Urol"},{"issue":"4","key":"1973_CR3","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.clgc.2021.03.010","volume":"19","author":"M Deuker","year":"2021","unstructured":"Deuker M, Krimphove MJ, Stolzenbach LF, Coll\u00e0Ruvolo C, Nocera L, Mansour M, et al. Radical cystectomy vs. multimodality treatment in T2N0M0 bladder cancer: a population-based, age-matched analysis. Clin Genitourin Cancer. 2021;19(4):264\u201371.","journal-title":"Clin Genitourin Cancer"},{"issue":"9","key":"1973_CR4","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1002\/cam4.3835","volume":"10","author":"LK Ballas","year":"2021","unstructured":"Ballas LK, Navarro S, Luo C, Fossum CC, Farias A, Daneshmand S, et al. Disparities in male versus female oncologic outcomes following bladder preservation: a population-based cohort study. Cancer Med. 2021;10(9):3004\u201312.","journal-title":"Cancer Med"},{"issue":"6","key":"1973_CR5","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S1470-2045(23)00170-5","volume":"24","author":"AR Zlotta","year":"2023","unstructured":"Zlotta AR, Ballas LK, Niemierko A, Lajkosz K, Kuk C, Miranda G, et al. Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis. Lancet Oncol. 2023;24(6):669\u201381.","journal-title":"Lancet Oncol"},{"key":"1973_CR6","unstructured":"The R Project for Statistical Computing. https:\/\/www.r-project.org."},{"issue":"5","key":"1973_CR7","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.ijrobp.2016.08.023","volume":"96","author":"KS Mak","year":"2016","unstructured":"Mak KS, Smith AB, Eidelman A, Clayman R, Niemierko A, Cheng JS, et al. Quality of life in long-term survivors of muscle-invasive bladder cancer. Int J Radiat Oncol *Biol* Phys. 2016;96(5):1028\u201336.","journal-title":"Int J Radiat Oncol *Biol* Phys"},{"issue":"8","key":"1973_CR8","doi-asserted-by":"publisher","first-page":"e191629","DOI":"10.1001\/jamasurg.2019.1629","volume":"154","author":"SB Williams","year":"2019","unstructured":"Williams SB, Shan Y, Ray-Zack MD, Hudgins HK, Jazzar U, Tyler DS, et al. Comparison of costs of radical cystectomy vs trimodal therapy for patients with localized muscle-invasive bladder cancer. JAMA Surg. 2019;154(8):e191629.","journal-title":"JAMA Surg"},{"issue":"4","key":"1973_CR9","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s10552-022-01553-2","volume":"33","author":"E Freudenburg","year":"2022","unstructured":"Freudenburg E, Shan Y, Martinez A, Srinivasan A, Movva G, Yu A, et al. Geographic distribution of racial differences in mortality in muscle-invasive bladder cancer patients: an opportunity for improvement. Cancer Causes Control. 2022;33(4):613\u201322.","journal-title":"Cancer Causes Control"},{"issue":"1","key":"1973_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12967-020-02308-w","volume":"18","author":"W Fang","year":"2020","unstructured":"Fang W, Yang ZY, Chen TY, Shen XF, Zhang C. Ethnicity and survival in bladder cancer: a population-based study based on the SEER database. J Transl Med. 2020;18(1):145.","journal-title":"J Transl Med"},{"issue":"1","key":"1973_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.eururo.2022.11.023","volume":"84","author":"EJ Schafer","year":"2023","unstructured":"Schafer EJ, Jemal A, Wiese D, Sung H, Kratzer TB, Islami F, et al. Disparities and trends in genitourinary cancer incidence and mortality in the USA. Eur Urol. 2023;84(1):117\u201326.","journal-title":"Eur Urol"},{"issue":"11","key":"1973_CR12","doi-asserted-by":"publisher","first-page":"456.e13","DOI":"10.1016\/j.urolonc.2023.08.003","volume":"41","author":"S Moon","year":"2023","unstructured":"Moon S, Pandya V, McDonald A, Basu A, Bae S, Ferguson JE. Analysis of treatment of muscle invasive bladder cancer using the national cancer database: factors associated with receipt of aggressive therapy. Urol Oncol Semi Original Investig. 2023;41(11):456.e13-456.e20.","journal-title":"Urol Oncol Semi Original Investig"},{"issue":"1","key":"1973_CR13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.eururo.2014.01.009","volume":"67","author":"ZD Reardon","year":"2015","unstructured":"Reardon ZD, Patel SG, Zaid HB, Stimson CJ, Resnick MJ, Keegan KA, et al. Trends in the use of perioperative chemotherapy for localized and locally advanced muscle-invasive bladder cancer: a sign of changing tides. Eur Urol. 2015;67(1):165\u201370.","journal-title":"Eur Urol"},{"issue":"6","key":"1973_CR14","doi-asserted-by":"publisher","first-page":"565","DOI":"10.4111\/icu.20200132","volume":"61","author":"C McFerrin","year":"2020","unstructured":"McFerrin C, Davaro F, May A, Raza S, Siddiqui S, Hamilton Z. Trends in utilization of neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer. Investig Clin Urol. 2020;61(6):565.","journal-title":"Investig Clin Urol"},{"issue":"8","key":"1973_CR15","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1002\/cncr.31926","volume":"125","author":"AP Cole","year":"2019","unstructured":"Cole AP, Fletcher SA, Berg S, Nabi J, Mahal BA, Sonpavde GP, et al. Impact of tumor, treatment, and access on outcomes in bladder cancer: can equal access overcome race-based differences in survival? Cancer. 2019;125(8):1319\u201329.","journal-title":"Cancer"},{"issue":"6","key":"1973_CR16","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","volume":"5","author":"N Lobo","year":"2022","unstructured":"Lobo N, Afferi L, Moschini M, Mostafid H, Porten S, Psutka SP, et al. Epidemiology, screening, and prevention of bladder cancer. Eur Urol Oncol. 2022;5(6):628\u201339.","journal-title":"Eur Urol Oncol"},{"key":"1973_CR17","doi-asserted-by":"crossref","unstructured":"Gild P, Wankowicz SA, Sood A, von Landenberg N, Friedlander DF, Alanee S, et al. Racial disparity in quality of care and overall survival among black vs. white patients with muscle-invasive bladder cancer treated with radical cystectomy: a national cancer database analysis. Urol Oncol Semin Orig Investig 2018; 36(10):469.e1\u2013469.e11.","DOI":"10.1016\/j.urolonc.2018.07.012"},{"issue":"7","key":"1973_CR18","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/cncr.28520","volume":"120","author":"DA Barocas","year":"2014","unstructured":"Barocas DA, Alvarez J, Koyama T, Anderson CB, Gray DT, Fowke JH, et al. Racial variation in the quality of surgical care for bladder cancer. Cancer. 2014;120(7):1018\u201325.","journal-title":"Cancer"},{"issue":"9","key":"1973_CR19","first-page":"410.e19","volume":"40","author":"S You","year":"2022","unstructured":"You S, Kim M, Widen S, Yu A, Galvan GC, Choi-Kuaea Y, et al. Characterizing molecular subtypes of high-risk non-muscle-invasive bladder cancer in African American patients. Urol Oncol Semin Orig Investig. 2022;40(9):410.e19-410.e27.","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"7","key":"1973_CR20","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s11255-022-03221-5","volume":"54","author":"F Chierigo","year":"2022","unstructured":"Chierigo F, Borghesi M, W\u00fcrnschimmel C, Flammia RS, Horlemann B, Sorce G, et al. Life expectancy in metastatic urothelial bladder cancer patients according to race\/ethnicity. Int Urol Nephrol. 2022;54(7):1521\u20137.","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"1973_CR21","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12967-020-02308-w","volume":"18","author":"W Fang","year":"2020","unstructured":"Fang W, Yang ZY, Chen TY, Shen XF, Zhang C. Ethnicity and survival in bladder cancer: a population-based study based on the SEER database. J Transl Med. 2020;18(1):145.","journal-title":"J Transl Med"},{"key":"1973_CR22","doi-asserted-by":"crossref","unstructured":"Horlemann B, W\u00fcrnschimmel C, Hoeh B, Sorce G, Chierigo F, Flammia RS, et al. Radical cystectomy vs. radiotherapy in urothelial bladder cancer in elderly and very elderly patients. Clin Genitourin Cancer. 2022;20(1):93.e1\u201393.e9.","DOI":"10.1016\/j.clgc.2021.08.003"},{"issue":"4","key":"1973_CR23","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s13566-017-0319-2","volume":"6","author":"M Korpics","year":"2017","unstructured":"Korpics M, Block AM, Altoos B, Martin B, Carey K, Welsh J, et al. Maximizing survival in patients with muscle-invasive bladder cancer undergoing curative bladder-preserving radiotherapy: the impact of radiotherapy dose escalation. J Radiat Oncol. 2017;6(4):387\u201395.","journal-title":"J Radiat Oncol"},{"issue":"1","key":"1973_CR24","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.eururo.2007.12.031","volume":"54","author":"HW Herr","year":"2008","unstructured":"Herr HW. Outcome of patients who refuse cystectomy after receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer. Eur Urol. 2008;54(1):126\u201332.","journal-title":"Eur Urol"},{"issue":"16","key":"1973_CR25","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1056\/NEJMoa1106106","volume":"366","author":"ND James","year":"2012","unstructured":"James ND, Hussain SA, Hall E. Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer. N Engl J Med. 2012;366(16):1477\u201388.","journal-title":"N Engl J Med"},{"issue":"5","key":"1973_CR26","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.juro.2018.06.001","volume":"200","author":"F Audenet","year":"2018","unstructured":"Audenet F, Waingankar N, Ferket BS, Niglio SA, Marqueen KE, Sfakianos JP, et al. Effectiveness of transurethral resection plus systemic chemotherapy as definitive treatment for muscle invasive bladder cancer in population level data. J Urol. 2018;200(5):996\u20131004.","journal-title":"J Urol"}],"container-title":["Journal of Racial and Ethnic Health Disparities"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-024-01973-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40615-024-01973-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-024-01973-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T18:02:34Z","timestamp":1747072954000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40615-024-01973-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,20]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1973"],"URL":"https:\/\/doi.org\/10.1007\/s40615-024-01973-7","relation":{},"ISSN":["2197-3792","2196-8837"],"issn-type":[{"value":"2197-3792","type":"print"},{"value":"2196-8837","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,20]]},"assertion":[{"value":"2 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All analyses and their reporting followed the SEER reporting guidelines. Due to the anonymously coded design of the SEER database, study-specific institutional review board ethics approval was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}